Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of various serious chronic diseases, such as diabetes, hemophilia, and thyroid disease. Sernova Corp. has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected therapeutic cells; and a research agreement with the University of Miami to advance the development of Cell Pouch cell therapy platform. The company was incorporated in 1998 and is headquartered in London, Canada.

Biotecnología

Dr. Philip M. Toleikis B.A., M.Sc., Ph.D.

Pres, Chief Technology Officer & Director

Ms. Cynthia  Pussinen

Chief Executive Officer & Director

Pres, Chief Technology Officer, Director of Technology & Director

Dr. Modestus  Obochi M.B.A., Ph.D.

Chief Bus. Officer

Mr. Frank A. Holler MBA

Executive Chairman

Mr. David  Swetlow C.A, C.A., CPA

Chief Financial Officer

Mr. Christopher  Barnes

Vice President of Investor Relations

Dr. Frank  Shannon M.D.

Vice President of Clinical Devel. & Regulatory Affairs

Mr. Douglas  Maret

Chief Science Officer

Pres, Chief Executive Officer & Director

Nombre	Capitalización
hVIVO plc	0M
VistaGen Therapeutics, Inc.	0M
Exopharm Limited	0M
Yunnan Botanee Bio-Technology Group Co.LTD	0M
BioVaxys Technology Corp.	0M
MedMira Inc.	0M
Regenicin, Inc.	0M
Vascular Biogenics Ltd.	0M
CorMedix Inc.	0M
Wave Life Sciences Ltd.	0M

Sernova Corp.

Sernova Corp. Lista de competidores

Principales competidores